Human Humanin (MT-RNR2) ELISA Kits

SOL #: PCA-NIA-02859Pre-Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

Bethesda, MD

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 1, 2026
2
Response Deadline
Apr 6, 2026, 1:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), has issued a combined synopsis/solicitation for Human Humanin (MT-RNR2) ELISA Kits. This procurement aims to acquire 49 kits to support an ongoing longitudinal study on age-related chronic diseases. The solicitation is conducted under Simplified Acquisition Procedures and Acquisition of Commercial Items. Quotes are due April 6, 2026, at 9:00 A.M. EDT.

Scope of Work

The requirement is for 49 Human Humanin ELISA Kits to measure humanin levels in human serum for research continuity. The kits must meet specific salient characteristics: ELISA technology, 96-well format, ability to assay humanin in 96 samples, sensitivity <7 pg/ml, require <50 ul serum, and compatibility with SpectraMax M2 Microplate Reader. Crucially, the kits must be the Human Putative Humanin Peptide (MT-RNR2) ELISA kits (CSB-EL015084HU) to ensure direct comparability with previous research data. Delivery is required within two weeks after receipt of order (ARO).

Contract & Timeline

  • Type: Firm Fixed-Price Purchase Order (Combined Synopsis/Solicitation)
  • NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
  • FAR: Part 13 (Simplified Acquisition Procedures) and Part 12 (Acquisition of Commercial Items)
  • Set-Aside: No specific set-aside mentioned.
  • Quotes Due: April 6, 2026, 9:00 A.M. EDT
  • Questions Due: April 3, 2026, 1:00 P.M. EDT
  • Published: April 1, 2026

Evaluation

Award will be made on a Lowest Price Technically Acceptable (LPTA) basis. Technical evaluation criteria include Technical Capability and Functionality, Contract Management and Customer Support, and Past Performance (minimum 1 year in relevant services/deliveries, at least one reference within the past three years). Price quotes will be evaluated for reasonableness.

Submission Requirements

Offerors must submit:

  • A technical quote (searchable PDF)
  • A price quote (Excel format)
  • Unique Entity Identifier (UEI) number
  • Verification of System for Award Management (SAM) Registration
  • Completed FAR clause 52.212-3, Offeror Representations and Certifications

Submissions must be in searchable electronic format and sent to Nicholas.capobianco@nih.gov.

Additional Notes

This is a combined synopsis/solicitation, constituting the only solicitation. Offerors must have an active SAM registration. The place of performance is Bethesda, MD.

People

Points of Contact

CAPOBIANCO, NICHOLAS SPRIMARY

Files

Files

Download
Download

Versions

Version 1Viewing
Pre-Solicitation
Posted: Apr 1, 2026
Human Humanin (MT-RNR2) ELISA Kits | GovScope